Financial News
Ozempic maker Novo Nordisk lowers growth outlook for its weight loss drugs as pricing pressures mount
Ozempic maker Novo Nordisk lowers growth outlook for its weight loss drugs as pricing pressures mount
More in Financial News
-
Social Security’s 2.8% COLA for 2026 is sparking debate over how the annual increase gets calculated
The Social Security cost-of-living adjustment for 2026 will not be a windfall for the...
-
Toyota recalling more than million vehicles in U.S. due to rear camera flaw
Toyota is recalling more than a million vehicles in the U.S. due to a...
-
Government shutdown live updates as Trump set to meet with Senate Republicans amid longest impasse in history
Politics Reporter Kaia Hubbard is a politics reporter for CBS News Digital, based in...
-
David Beckham calls being knighted by King Charles his “proudest moment”
London — When it came time to receive his knighthood, soccer great David Beckham...

